# Veru Inc.: filings

VERU · Nasdaq · CIK 863894 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/veru.md) · [Financials](/companies/veru/financials.md) · [Filings](/companies/veru/filings.md) · [Insiders](/companies/veru/insiders.md)

## Reports and events: 295 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 427, 8-K 193, DEFA14A 57, 10-Q 54, 3 23, SC 13G/A 23, DEF 14A 21, SC 13G 19, 10-K 17, 424B5 15, UPLOAD 13, CORRESP 11, 4/A 9, S-8 9, EFFECT 8, ARS 7, 3/A 6, S-3 6, PRE 14A 4, 8-K/A 3, 10-K/A 2, NO ACT 2, POS AM 2, PRER14A 2, S-8 POS 2, SC 13D 2, SC 13D/A 2, SCHEDULE 13G/A 2, 10-Q/A 1, 25 1, 8-A12B 1, CERTNAS 1, D 1, DEFM14A 1, DEFR14A 1, NT 10-K 1, NT 10-Q 1, PREM14A 1, S-3/A 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 08:17 ET | [8-K](/filings/0001193125-26-384430.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-384430 |
| 2026-08-10 | 08:51 ET | [10-Q](/filings/0001437749-26-026664.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026664 |
| 2026-08-10 | 07:00 ET | [8-K](/filings/0001193125-26-341187.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-341187 |
| 2026-07-02 | 16:08 ET | [8-K](/filings/0001193125-26-294507.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-294507 |
| 2026-06-04 | 08:30 ET | [8-K](/filings/0001437749-26-019478.md) | 8.01 Other events | 0001437749-26-019478 |
| 2026-05-13 | 09:09 ET | [10-Q](/filings/0001437749-26-016557.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016557 |
| 2026-05-13 | 07:00 ET | [8-K](/filings/0001193125-26-220569.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-220569 |
| 2026-03-13 | 16:04 ET | [8-K](/filings/0001437749-26-008216.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-008216 |
| 2026-02-11 | 10:32 ET | [10-Q](/filings/0001437749-26-003725.md) | Quarterly report, period 2025-12-31 | 0001437749-26-003725 |
| 2026-02-11 | 07:00 ET | [8-K](/filings/0001193125-26-045527.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-045527 |
| 2026-01-28 | 16:06 ET | [DEF 14A](/filings/0001140361-26-002671.md) | Proxy statement, period 2026-03-12 | 0001140361-26-002671 |
| 2025-12-17 | 10:49 ET | [10-K](/filings/0001437749-25-038089.md) | Annual report, period 2025-09-30 | 0001437749-25-038089 |
| 2025-12-17 | 07:00 ET | [8-K](/filings/0001193125-25-321663.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-321663 |
| 2025-10-30 | 16:15 ET | [8-K](/filings/0001193125-25-258565.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-258565 |
| 2025-09-26 | 08:59 ET | [8-K](/filings/0001437749-25-029912.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-029912 |
| 2025-08-27 | 16:05 ET | [8-K](/filings/0001437749-25-027858.md) | 8.01 Other events | 0001437749-25-027858 |
| 2025-08-12 | 10:44 ET | [10-Q](/filings/0001437749-25-026072.md) | Quarterly report, period 2025-06-30 | 0001437749-25-026072 |
| 2025-08-12 | 07:30 ET | [8-K](/filings/0001437749-25-026037.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-026037 |
| 2025-08-12 | 07:00 ET | [8-K](/filings/0001193125-25-178463.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-178463 |
| 2025-07-25 | 16:07 ET | [8-K](/filings/0001437749-25-023521.md) | 5.07 Shareholder vote results | 0001437749-25-023521 |
| 2025-06-10 | 16:17 ET | [DEF 14A](/filings/0001140361-25-022074.md) | Proxy statement, period 2025-07-25 | 0001140361-25-022074 |
| 2025-05-08 | 11:51 ET | [10-Q](/filings/0001437749-25-015330.md) | Quarterly report, period 2025-03-31 | 0001437749-25-015330 |
| 2025-05-08 | 07:01 ET | [8-K](/filings/0001193125-25-115453.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-115453 |
| 2025-03-14 | 16:28 ET | [8-K](/filings/0001437749-25-007742.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-25-007742 |
| 2025-02-28 | 16:05 ET | [8-K](/filings/0001193125-25-042467.md) | 3.01 Delisting notice | 0001193125-25-042467 |
| 2025-02-13 | 14:35 ET | [10-Q](/filings/0001437749-25-003734.md) | Quarterly report, period 2024-12-31 | 0001437749-25-003734 |
| 2025-02-13 | 07:00 ET | [8-K](/filings/0001193125-25-025576.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-025576 |
| 2025-01-28 | 13:14 ET | [DEF 14A](/filings/0001140361-25-002147.md) | Proxy statement, period 2025-03-13 | 0001140361-25-002147 |
| 2025-01-03 | 16:02 ET | [8-K](/filings/0001437749-25-000208.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 2.04 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-000208 |
| 2024-12-16 | 15:48 ET | [10-K](/filings/0001437749-24-037576.md) | Annual report, period 2024-09-30 | 0001437749-24-037576 |
| 2024-09-20 | 16:11 ET | [8-K](/filings/0001193125-24-222901.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-222901 |
| 2024-08-30 | 16:08 ET | [8-K](/filings/0001193125-24-211075.md) | 3.01 Delisting notice | 0001193125-24-211075 |
| 2024-08-23 | 16:05 ET | [8-K](/filings/0001193125-24-206171.md) | 1.02 Termination of a material agreement | 0001193125-24-206171 |
| 2024-08-08 | 10:45 ET | [10-Q](/filings/0001437749-24-025338.md) | Quarterly report, period 2024-06-30 | 0001437749-24-025338 |
| 2024-08-08 | 07:01 ET | [8-K](/filings/0001193125-24-196459.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-196459 |
| 2024-08-02 | 16:07 ET | [8-K](/filings/0001193125-24-192858.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-192858 |
| 2024-07-02 | 16:14 ET | [8-K](/filings/0001193125-24-174334.md) | 5.07 Shareholder vote results | 0001193125-24-174334 |
| 2024-06-21 | 16:25 ET | [8-K](/filings/0001193125-24-165716.md) | 5.07 Shareholder vote results | 0001193125-24-165716 |
| 2024-05-22 | 16:10 ET | [8-K](/filings/0001193125-24-144951.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-24-144951 |
| 2024-05-08 | 13:09 ET | [10-Q](/filings/0000863894-24-000011.md) | Quarterly report, period 2024-03-31 | 0000863894-24-000011 |
| 2024-05-08 | 07:00 ET | [8-K](/filings/0001193125-24-133757.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-133757 |
| 2024-04-26 | 16:27 ET | [8-K](/filings/0001193125-24-118157.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-118157 |
| 2024-04-25 | 07:02 ET | [8-K](/filings/0001193125-24-111507.md) | 8.01 Other events | 0001193125-24-111507 |
| 2024-04-01 | 15:42 ET | [10-Q](/filings/0000863894-24-000008.md) | Quarterly report, period 2023-12-31 | 0000863894-24-000008 |
| 2024-04-01 | 15:30 ET | [10-K/A](/filings/0000863894-24-000006.md) | Annual report, amended, period 2023-09-30 | 0000863894-24-000006 |
| 2024-02-28 | 18:47 ET | [8-K](/filings/0001193125-24-048246.md) | 3.01 Delisting notice | 0001193125-24-048246 |
| 2024-02-15 | 16:06 ET | [8-K](/filings/0001193125-24-037535.md) | 4.02 Non-reliance on financial statements | 0001193125-24-037535 |
| 2024-02-08 | 07:00 ET | [8-K](/filings/0001193125-24-027504.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-027504 |
| 2024-01-26 | 16:06 ET | [8-K](/filings/0001193125-24-016705.md) | 3.01 Delisting notice | 0001193125-24-016705 |
| 2024-01-26 | 09:00 ET | [DEF 14A](/filings/0001140361-24-003976.md) | Proxy statement, period 2024-03-26 | 0001140361-24-003976 |

Page 1 of 6. [Older](/companies/veru/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.